• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hemogenyx Pharmaceuticals Plc. (OP:HOPHF)

2.330 UNCHANGED
Last Price Updated: 12:20 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hemogenyx Pharmaceuticals Plc.

< Previous 1 2 3 4 Next >
Hemogenyx Pharmaceuticals discusses successful £3.5M capital raise as it advances HEMO-CAR-T program
March 12, 2024
--News Direct-- 
Via News Direct
Hemogenyx Pharmaceuticals discusses successful £3.5M capital raise as it advances HEMO-CAR-T program
March 12, 2024
Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) Dr Vladislav Sandler joins Proactive's Stephen Gunnion after the pre-clinical stage biopharmaceutical group raised £3.5 million, which will be... 
Via TheNewswire.com
News headline image
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise US$4.2 million
February 28, 2024
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces CBR Brain Delivery
February 15, 2024
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces CBR Intranasal Delivery
February 13, 2024
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces FDA Consents to Phase I Trials of HEMO-CAR-T
February 08, 2024
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces the Approval and Issuance of U.S. Conditioning Patent
February 01, 2024
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Submission of Complete Response to Clinical Hold
January 15, 2024
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces CBR Expanded to Treatment of Cancer
November 27, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Qualification Run Completed
January 07, 2024
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £534,375
November 28, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Lentivirus Re-manufacturing Completed
November 15, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC
September 18, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC - Clinical Hold Lift Plan is accepted by FDA
September 14, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
July 03, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Clinical Hold on IND for HEMO-CAR-T
June 02, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Equity Incentive Pool Increase and Option Grant
April 28, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
February 28, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces CBR Patent Application Update
September 08, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Full FDA Review for HEMO-CAR-T IND
July 10, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Submission of IND for HEMO-CAR-T
May 09, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Final Results for the Year Ended 31 December 2022
April 28, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC - HEMO-CAR-T First PQ Run Completed
December 12, 2022
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
September 29, 2022
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Analytical Release Tests Completed
March 23, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £4,056,250
January 26, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T 3rd Process Qualification Run Completed
January 23, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces Single CBR Can Treat Multiple Viruses
January 09, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Qualification Run Completed
January 04, 2023
Via ACCESSWIRE
News headline image
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Development Runs Completed
November 18, 2022
Via ACCESSWIRE
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap